Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Saint Regis Mohawk Tribe v. Mylan Pharmaceuticals Inc.
Case Number:
18-1643
Court:
Nature of Suit:
Companies
Government Agencies
Sectors & Industries:
-
June 04, 2018
Fed. Circ. Weighs Immunity From IPR In Tribal IP Transfer
A Federal Circuit panel Monday grilled attorneys for the St. Regis Mohawk Tribe, the federal government and a group of pharmaceutical companies over whether patents transferred to tribal nations are shielded from inter partes review by sovereign immunity.
-
June 01, 2018
Tribal Immunity At The Fed. Circ.: What You Need To Know
The Federal Circuit will hear arguments Monday on whether tribal sovereign immunity can insulate patents from review at the Patent Trial and Appeal Board, wading into an issue one judge has suggested could spell the end of the review proceedings.
-
May 16, 2018
DOJ, Microsoft Urge Fed. Circ. To Find Tribes Can Face IPRs
The Federal Circuit should uphold the Patent Trial and Appeal Board's decision saying that sovereign immunity doesn't apply to inter partes reviews because federal agencies are allowed to enforce federal law, even against states and Native American tribes, the U.S. Department of Justice, Microsoft Corp. and other amici told the court.
-
April 19, 2018
Allergan, Tribe Fight PTAB's Immunity Denial At Fed. Circ.
The Patent Trial and Appeal Board went against decades of U.S. Supreme Court precedent when it found that the St. Regis Mohawk Tribe isn't immune to inter partes reviews, the tribe and Allergan Inc. told the Federal Circuit on Wednesday in a closely watched case over dry eye medication patents.
-
March 28, 2018
Fed. Circ. Pauses PTAB Review Of Restasis Patents
The Federal Circuit on Wednesday ordered the Patent Trial and Appeal Board to pause its review of patents covering Allergan PLC's dry eye medication Restasis while the appeals court considers arguments that tribal immunity insulates the patents from proceedings at the board.